Valuation: Cosmos Health Inc.

Market Cap 25.06M 22.44M 20.71M 18.74M 35.04M 2.39B 35.6M 247M 98.55M 1.25B 94.04M 92.04M 3.96B P/E 2026 *
-1.66x
P/E 2027 * 3.56x
Enterprise Value 25.06M 22.44M 20.71M 18.74M 35.04M 2.39B 35.6M 247M 98.55M 1.25B 94.04M 92.04M 3.96B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.19x
Free-Float
74.12%
Yield 2026 *
-
Yield 2027 * -
1 day+9.24%
1 week+7.31%
Current month-36.85%
1 month-35.48%
3 months+48.60%
6 months-24.10%
Current year-45.48%
1 week 0.22
Extreme 0.2182
0.28
1 month 0.22
Extreme 0.2182
0.44
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
1.04
3 years 0.16
Extreme 0.1616
1.65
5 years 0.16
Extreme 0.1616
113.75
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 26/02/2016
Director of Finance/CFO 43 11/11/2020
Chief Operating Officer 56 01/02/2023
Director TitleAgeSince
Director/Board Member 58 13/01/2014
Chairman 60 26/02/2016
Director/Board Member 59 18/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/7/26 Buy

Chief Executive Officer

349,825 0.5635%
29/7/26 Free

Chief Financial Officer

328,407 0.5290%
29/7/26 Buy

Chief Executive Officer

766,284 1.2344%
Change 5-day change 1-year change 3-year change Capi.($)
+9.24%+7.31%-70.69%-73.64% 25.06M
+5.99%+4.80%+68.33%+142.08% 1,148B
+1.13%+2.62%+47.17%+86.78% 652B
+0.84%+1.11%+28.08%+103.22% 505B
+0.73%+2.45%+54.26%+66.47% 384B
+4.25%+0.43%+70.79%+44.01% 348B
+2.38%+2.65%+34.31%+56.33% 294B
+2.26%+0.55%+3.92%+27.74% 264B
+1.30%+2.45%+57.06%+74.12% 244B
+1.15%+2.39%+35.82%+106.96% 197B
Average +2.97%+0.12%+32.91%+63.41% 403.72B
Weighted average by Cap. +2.91%+1.50%+49.79%+93.10%

Financials

2026 *2027 *
Net sales 85.41M 76.5M 70.58M 63.87M 119M 8.13B 121M 842M 336M 4.26B 321M 314M 13.48B 130M 116M 107M 96.91M 181M 12.34B 184M 1.28B 510M 6.46B 486M 476M 20.46B
Net income 5.97M 5.34M 4.93M 4.46M 8.34M 568M 8.48M 58.82M 23.46M 297M 22.39M 21.91M 942M 8.81M 7.89M 7.28M 6.59M 12.32M 839M 12.52M 86.87M 34.66M 439M 33.07M 32.37M 1.39B
Net Debt - -
Projected Income Statement - Annual - Cosmos Health Inc.
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
30/10/26 USD 0.2715 +9.04% 1,192,294
28/10/26 USD 0.2490 +5.51% 2,631,620
27/10/26 USD 0.2360 +1.55% 2,299,933
26/10/26 USD 0.2324 -10.96% 3,309,286
23/10/26 USD 0.2610 +3.16% 2,677,959
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Cosmos Health Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2490USD
Average target price
2.950USD
Spread / Average Target
+1,084.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cosmos Health Inc.
  1. Stock Market
  2. Stocks
  3. COSM Stock